The 1 analysts offering 12-month price forecasts for ImmuCell Corp have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +149.55% increase from the last price of 5.61.
The current consensus among 1 polled investment analysts is to Buy stock in ImmuCell Corp. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.04
Reporting Date Feb 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.